Why is Bliss GVS Pharma falling/rising?

As of 18-Sep, Bliss GVS Pharma Ltd's stock price is currently at 153.75, reflecting an increase of 1.05 or 0.69%. The stock has shown a positive movement today, gaining for the last two consecutive days with a total return of 1.52%. It opened with a gain of 2.13% and reached an intraday high of Rs 155.95. However, despite this recent uptick, the stock has underperformed its sector by 0.36% today and has seen a significant decline of 11.84% over the past month. While the company has a low debt-to-equity ratio and a fair valuation, its profits have decreased by 3.6% over the past year, which may contribute to investor caution despite the stock's long-term performance being strong.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has increased by 1.80% over the past week and 2.14% over the past month. Year-to-date, Bliss GVS Pharma has underperformed the benchmark, with a decline of 6.62% compared to the Sensex's gain of 6.24%. This underperformance in the short term, coupled with falling investor participation indicated by a 59.76% drop in delivery volume, suggests a cautious sentiment among investors despite the stock's historical outperformance over longer periods.